Skip to main content
. 2022 Apr 26;23(9):4764. doi: 10.3390/ijms23094764

Figure 5.

Figure 5

Main findings regarding the alterations of the ECS components in animal models and patients with autism spectrum disorders. AEA: anandamide; CB1r: cannabinoid receptor 1; CB2r: cannabinoid receptor 2; FAAH: fatty acid amide hydrolase; HIPP: hippocampus; NAPE-PLD: N-acyl phosphatidylethanolamine phospholipase, NAE: N- acetyl ethanolamine.